173 related articles for article (PubMed ID: 30347895)
1. Sialic Acid-Binding Lectin from Bullfrog Eggs Exhibits an Anti-Tumor Effect Against Breast Cancer Cells Including Triple-Negative Phenotype Cells.
Tatsuta T; Sato S; Sato T; Sugawara S; Suzuki T; Hara A; Hosono M
Molecules; 2018 Oct; 23(10):. PubMed ID: 30347895
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid-binding lectin from bullfrog eggs inhibits human malignant mesothelioma cell growth in vitro and in vivo.
Tatsuta T; Satoh T; Sugawara S; Hara A; Hosono M
PLoS One; 2018; 13(1):e0190653. PubMed ID: 29298350
[TBL] [Abstract][Full Text] [Related]
3. RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3/7 signaling pathway in human breast cancer cells.
Kariya Y; Tatsuta T; Sugawara S; Kariya Y; Nitta K; Hosono M
Int J Oncol; 2016 Oct; 49(4):1334-42. PubMed ID: 27513956
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic alterations in malignant pleural mesothelioma cells in response to long‑term treatment with bullfrog sialic acid‑binding lectin.
Tatsuta T; Nakasato A; Sugawara S; Hosono M
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880588
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma.
Satoh T; Tatsuta T; Sugawara S; Hara A; Hosono M
Oncotarget; 2017 Jun; 8(26):42466-42477. PubMed ID: 28476017
[TBL] [Abstract][Full Text] [Related]
6. Effect of modification of the carboxyl groups of the sialic acid binding lectin from bullfrog (Rana catesbeiana) oocyte on anti-tumor activity.
Iwama M; Ogawa Y; Sasaki N; Nitta K; Takayanagi Y; Ohgi K; Tsuji T; Irie M
Biol Pharm Bull; 2001 Sep; 24(9):978-81. PubMed ID: 11558580
[TBL] [Abstract][Full Text] [Related]
7. [Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer Treatment].
Tatsuta T
Yakugaku Zasshi; 2022; 142(10):1045-1053. PubMed ID: 36184438
[TBL] [Abstract][Full Text] [Related]
8. Discovery of antitumor effects of leczymes.
Tatsuta T; Hosono M
Glycoconj J; 2022 Apr; 39(2):157-165. PubMed ID: 35066741
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Hsp70 inhibits apoptosis induced by sialic acid-binding lectin (leczyme).
Tatsuta T; Hosono M; Ogawa Y; Inage K; Sugawara S; Nitta K
Oncol Rep; 2014 Jan; 31(1):13-8. PubMed ID: 24173532
[TBL] [Abstract][Full Text] [Related]
10. Leczyme: a new candidate drug for cancer therapy.
Tatsuta T; Sugawara S; Takahashi K; Ogawa Y; Hosono M; Nitta K
Biomed Res Int; 2014; 2014():421415. PubMed ID: 24864241
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL.
Tatsuta T; Hosono M; Takahashi K; Omoto T; Kariya Y; Sugawara S; Hakomori S; Nitta K
Int J Oncol; 2014 Feb; 44(2):377-84. PubMed ID: 24297392
[TBL] [Abstract][Full Text] [Related]
12. Effect of replacing the aspartic acid/glutamic acid residues of bullfrog sialic acid binding lectin with asparagine/glutamine and arginine on the inhibition of cell proliferation in murine leukemia P388 cells.
Ogawa Y; Iwama M; Ohgi K; Tsuji T; Irie M; Itagaki T; Kobayashi H; Inokuchi N
Biol Pharm Bull; 2002 Jun; 25(6):722-7. PubMed ID: 12081136
[TBL] [Abstract][Full Text] [Related]
13. Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs.
Nitta K; Ozaki K; Tsukamoto Y; Hosono M; Ogawakonno Y; Kawauchi H; Takayanagi Y; Tsuiki S; Hakomori S
Int J Oncol; 1996 Jul; 9(1):19-23. PubMed ID: 21541475
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
[TBL] [Abstract][Full Text] [Related]
15. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.
Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N
Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240
[TBL] [Abstract][Full Text] [Related]
16. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
18. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic properties of sialic acid binding lectin from Rana catesbeiana modified with a water-soluble carbodiimide in the presence of various nucleophiles.
Iwama M; Ogawa Y; Ohgi K; Tsuji T; Irie M
Biol Pharm Bull; 2001 Dec; 24(12):1366-9. PubMed ID: 11767103
[TBL] [Abstract][Full Text] [Related]
20. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
